David John GRAINGER
Born Oct 1966 · 22 appointments total
Director DNA
Distress-adjacent pattern
9 of 22 appointments (41%) are at companies that became distressed, dissolved, or entered insolvency. Worth investigating outcomes.
🔒Director net-worth aggregation
Combined net worth, cash, assets and liabilities across this director's 12 active directorships.
Available from the Pro tier upwards.
See pricing →Active appointments
13
Former appointments
9
Dissolved companies
9
41% of total
Median tenure
5.1y
Reliability
50/100
Based on tenure, outcomes, admin discipline
Distress adjacency
33/100
Exposure to dissolved / liquidated companies
Admin discipline
50/100
Inferred from appointment patterns
Active appointments (13)
active
active
active
active
active
active
active
active
active
active
dissolved
active
dissolved
Former appointments (9)
CENTESSA PHARMACEUTICALS (OREXIA) LIMITED
dissolved11607013 · director
appointed 2021-11-30 · resigned 2023-08-18 · 1.7y tenure
LOCKBODY THERAPEUTICS LTD
dissolved10650186 · director
appointed 2021-11-30 · resigned 2023-08-18 · 1.7y tenure
dissolved
dissolved
CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED
dissolved09686738 · director
appointed 2021-11-30 · resigned 2023-08-18 · 1.7y tenure
dissolved
dissolved
active
PANDEIA THERAPEUTICS LIMITED
active11463856 · director
appointed 2019-09-19 · resigned 2022-12-22 · 3.3y tenure